Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stressYasumasa Ikeda, Toshiaki Tamaki, Licht Miyamoto et al.|The FASEB Journal|2019Cited by 51
Study on the Optimal Dose of Irinotecan for Patients with Heterozygous Uridine Diphosphate-Glucuronosyltransferase 1A1 (<i>UGT1A1</i>)Ken Konaka, Keisuke Ishizawa, Masaki Imanishi et al.|Biological and Pharmaceutical Bulletin|2019Cited by 6
Fibroblast-specific ERK5 deficiency changes tumor vasculature and exacerbates tumor progression in a mouse modelMasaki Imanishi, Keisuke Ishizawa, Yusuke Yamakawa et al.|Naunyn-Schmiedeberg s Archives of Pharmacology|2020Cited by 4
Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective studyTakumi Sakurada, Keisuke Ishizawa, Sanako Bando et al.|Cancer Chemotherapy and Pharmacology|2019Cited by 3
Search for preventive drugs against oxaliplatin-induced peripheral neuropathy through drug repositioningTakahiro Niimura, Keisuke Ishizawa, Yoshito Zamami et al.|Proceedings for Annual Meeting of The Japanese Pharmacological Society|2019Cited by 0